Dry eye showdown: light therapy vs warm compress – but study never started
NCT ID NCT04920396
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study planned to compare intense regulated pulsed light (IRPL) therapy with daily warm compresses for people with dry eye caused by meibomian gland dysfunction. Researchers aimed to measure symptom scores and tear film stability. However, the trial was withdrawn before enrolling any participants, so no data were collected.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Intense regulated pulsed light (IRPL) therapy device
- What this could lead to
- If it worked, IRPL could offer a more effective option than warm compresses for relieving dry eye symptoms.
- What could go wrong
- The trial was withdrawn with no participants enrolled, so no results exist. IRPL may not prove better than standard care.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MEIBOMIAN GLAND DYSFUNCTION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Market Mall Eye Clinic - Calgary, AB
Calgary, Alberta, AB T3A 0E2, Canada
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a nasal spray soothe dry eyes? new study investigates
- Can radio waves zap dry eye away? new trial tests device for stubborn cases
- New heat therapy for dry eyes could beat old warm compress routine
- Warm compresses vs. High-Tech eye gadgets: which best treats dry eye?
- Shedding light on dry eye: new study tests IPL and LED mask therapies
- Warm compress device shows promise for dry eyes before cataract surgery